MHRA and Swissmedic sign MoU on improving international collaboration

11 October 2016

With around 75 agency representatives from 23 countries attending, the two-day summit is being held in Switzerland for the first time and organized by Swissmedic, the Swiss Agency for Therapeutic Products.

The objective of the annual meeting of medicinal and therapeutic products authorities is to promote information sharing and improve networking among agencies. The topics on the agenda of the 11th Summit of Heads of Medicines Regulatory Agencies in Interlaken, Switzerland, include regulatory transparency, as well as best practices in cooperation and dialogue with stakeholders.

As part of the 11th Summit of the Heads of Medicines Regulatory Agencies, the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has signed a memorandum of understanding (MoU) with its Swiss counterpart, Swissmedic.

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK